Transmissible Spongiform Encephalopathies Advisory Committee
December 15, 2006 Meeting
Date and Time:
The meeting will be held on December 15, 2006, 8 a.m. to 3:30 p.m.
Location:
Crown Plaza Silver Spring, 8777 Georgia Ave., Silver Spring, MD 20910, 301-589-0800.
Contact Person:
William Freas, or Rosanna L. Harvey, 301-827-0314, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 3014512392. Please call the Information Line for up-to-date information on this meeting.
Agenda:
On December 15, 2006, the Committee will discuss FDA's risk assessment for potential exposure to vCJD in human plasma-derived antihemophilic factor (FVIII) products manufactured from US plasma donors and related communication materials. In the afternoon, the Committee will discuss levels of transmissible spongiform encephalopathy clearance in the manufacture of plasma-derived Factor VIII products.
Oral Presentations:
Oral presentations from the public will be scheduled between approximately 10:25 and 10:55 a.m. and 1:35 and 2:05 p.m. on December 15, 2006. Those desiring to make formal oral presentations should notify the contact person on or before December 7, 2006.